3//SEC Filing
Versant Venture Capital IV, L.P. 3
Accession 0001209191-18-057892
CIK 0001410939other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 1:48 PM ET
Size
10.1 KB
Accession
0001209191-18-057892
Insider Transaction Report
Form 3
Ophthotech Corp.OPHT
Versant Side Fund IV, L.P.
10% Owner
Holdings
- 5,012,624(indirect: See footnote)
Common Stock
- 31,577(indirect: See footnote)
Common Stock
Versant Ventures IV, LLC
10% Owner
Holdings
- 5,012,624(indirect: See footnote)
Common Stock
- 31,577(indirect: See footnote)
Common Stock
Versant Venture Capital IV, L.P.
10% Owner
Holdings
- 5,012,624(indirect: See footnote)
Common Stock
- 31,577(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]This report on Form 3 is jointly filed by Versant Venture Capital IV, L.P. ("VVC IV") and Versant Side Fund IV, L.P. ("VSF IV"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such entity is a beneficial owner of such securities for the purpose of Section 16 or for any other purpose.
- [F2]These securities are held of record by VVC IV. Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley Bolzon, Ph.D., Charles M. Warden, Kirk G. Nielsen, Thomas Woiwode and Robin L. Praeger are managing directors of VV IV and share voting and dispositive power over the shares held by VVC IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein.
- [F3]These securities are held of record by VSF IV. VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley Bolzon, Ph.D., Charles M. Warden, Kirk G. Nielsen, Thomas Woiwode and Robin L. Praeger are managing directors of VV IV and share voting and dispositive power over the shares held by VSF IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein.
Documents
Issuer
Ophthotech Corp.
CIK 0001410939
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001456590
Filing Metadata
- Form type
- 3
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 1:48 PM ET
- Size
- 10.1 KB